LifeVantage Corporation (OTC: LFVN), a science-based nutraceutical company, last week, reported its third-quarter financial results.
LFVN reported third-quarter revenue of $36.2 million, up 263% over the same period in the previous year. LFVN’s operating income for the quarter rose 709% over the same period last year to $6.4 million. Operating margin for the quarter was 17.7%, up from 7.9% reported for the same period in the previous year.
Douglas C. Robinson, President and CEO of LifeVantage, said that LFVN is pleased to report another record quarter. Robinson said that in the third quarter, LFVN significantly increased its top-line as well as its operating margins, while continuing to invest in its infrastructure by adding headcount, increasing its marketing efforts, and expanding its investment in research.
At the end of the third quarter, LFVN had cash balance of $16.9 million.
LFVN shares fell marginally in trading on Friday. The stock ended the day 2.77% lower at $3.16 on above average volume of 801,579.
Recent Comments